Description
BLOOD PRODUCTS
First action · last action
2009-10-01 · 2009-10-01
Transactions
1
First transaction's obligation
$132,000
Base + all options value (sum of deltas)
$132,000
Extent competed
FOLLOW ON TO COMPETED ACTION
Other than full & open authority
ONLY ONE SOURCE - OTHER
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
Parent IDV
V539P4441
NAICS
611310 · COLLEGES, UNIVERSITIES, AND PROFESSIONAL SCHOOLS
Modification chain · 1 transaction
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2009-10-01+$132,000= $132,000
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2009-10-01 | +$132,000 | $132,000 | BLOOD PRODUCTS |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI DZ4YCZ3QSPR5)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C25026P0503 | 250-NETWORK CONTRACT OFFICE 10 (36C250) · AN11 · HEALTH R&D SERVICES; HEALTH CARE SERVICES; BASIC RESEARCH | $23,896 | FY2026 |
| 36C25026P0345 | 250-NETWORK CONTRACT OFFICE 10 (36C250) · Q301 · REFERENCE LABORATORY TESTING | $300,000 | FY2026 |
| 36C25025P1761 | 250-NETWORK CONTRACT OFFICE 10 (36C250) · 6910 · TRAINING AIDS | $5,000 | FY2025 |
| 36C25025C0078 | 250-NETWORK CONTRACT OFFICE 10 (36C250) · 6506 · BLOOD AND BLOOD PRODUCTS | $300,000 | FY2025 |
| 36C24E24P0023 | RPO EAST (36C24E) · AJ11 · GENERAL SCIENCE AND TECHNOLOGY R&D SERVICES; GENERAL SCIENCE AND TECHNOLOGY; BASIC RESEARCH | $6,086 | FY2024 |
| 36C25024C0070 | 250-NETWORK CONTRACT OFFICE 10 (36C250) · 6505 · DRUGS AND BIOLOGICALS | $215,752 | FY2024 |
Other recipients under 6505 from 539-CINCINNATI (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| VA25016J0130 | SCHAAF DRUGS, LLC | 539-CINCINNATI | $600,000 | FY2016 |
| VA25015F0449 | CSL BEHRING L.L.C. | 539-CINCINNATI | $24,062 | FY2015 |
| VA25013F0466 | CSL BEHRING L.L.C. | 539-CINCINNATI | $42,276 | FY2013 |
| VA25013P0365 | GAMBRO RENAL PRODUCTS, INC. | 539-CINCINNATI | $7,554 | FY2013 |
| VA25013F0329 | CSL BEHRING L.L.C. | 539-CINCINNATI | $0 | FY2013 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA539C05110_3600_V539P4441_3600 · retrieved 2026-09-26.